MedPath

Clinical study on the maintenance treatment of advanced gastric cancer with the combination of disease and syndrome based on Sanlengxiaoliu Mixture

Phase 1
Conditions
gastric cancer
Registration Number
ITMCTR2000003692
Lead Sponsor
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine affiliated to Shanghai University of Traditional Chinese Medicine (TCM)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Patients with definite pathological classification of gastric cancer;
2. TNM stage IV;
3. The number of treatment cycles prescribed by first-line chemotherapy or targeted combined with first-line chemotherapy was completed, and the patients receiving single-drug chemotherapy or targeted combined with single-drug chemotherapy were treated with intervention;
4. Aged 18 to 75 years male or female;
5. Karnofsky score >=60;
7. Inspection and inspection standards: Hb>100g/L, white blood cell (WBC) >=4.0x10^9/L, neutrophil (ANC) >=2.0x10^9/L, platelet (PLT) >=100x10^9/L, normal cardiac, liver and renal function;
8. The informed consent of the patient was signed and the patient was followed up for a long time.

Exclusion Criteria

1. TNM stage I-III;
2. Patients with double or multiple cancers;
3. Pregnant women, lactating women, children and the mentally ill.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
PFS;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath